Monthly Archives: July 2017

DNA solved ‘cold case’ rape of developmentally disabled woman 16 … – WCPO

Posted: July 7, 2017 at 1:47 am

LEBANON, Ohio -- A DNA sample solved a rape cold case about 16 years after the crime, Warren County Prosecutor David Fornshell announced Thursday.

Sixteen years ago, nurses at Brookside Extended Care discovered one of their residents -- a 29-year-old woman with developmental disabilities so severe she could neither walk nor speak -- had been violently sexually assaulted by an unknown man overnight. Not one of them,Fornshell said, has ever been able to forget it.

"It's sickening to think that anybody would be capable of doing that to someone so vulnerable," he said.

The victim died in 2011. The only DNA evidence of the culprit's identity -- blood and semen found in the victim's diaper after the assault -- languished without matches for over a decade, and $6,000 in reward money didn't coax leads out of the surrounding community. Brookside made improvements to its security, including the installation of many alarms and surveillance cameras, but no suspects emerged.

Until Thursday.

Fornshell believes a DNA cross-check has successfully identified the culprit as Brian Sundin, a 42-year-old whose DNA was on file with the Florida Department of Corrections.

Sundin was with charged the rape in February after the match was made, but his indictment remained sealed while he was at large. According to a news release from Fornshell, he was recently arrested and convicted of a theft offense in Williamson County, Tennessee.

With Sundin already behind bars, Warren County authorities unsealed the indictment and began the process of extraditing him to Ohio.

Authorities believeSundin, who lived nearby at the time, entered Brookside through an unlocked door and assaulted the victim, according to the news release.

Although the victim is no longer living, Fornshell said everyone from doctors to detectives agreed the county should seek justice for her sake and that of her family.

"It's going to be a situation where no jury is going to believe she in any way consented to any of this happening," he said.

Visit link:
DNA solved 'cold case' rape of developmentally disabled woman 16 ... - WCPO

Posted in DNA | Comments Off on DNA solved ‘cold case’ rape of developmentally disabled woman 16 … – WCPO

Researchers explore DNA folding, cellular packing with supercomputer simulations – Phys.Org

Posted: at 1:47 am

July 6, 2017 Sequence-specific, twist-induced, kinked elastic configurations, generated by molecular dynamics simulations on supercomputers at the Texas Advanced Computing Center, help explain how long strands of DNA can fit in small spaces. Credit: Christopher G. Myers, B. Montgomery Pettitt, University of Texas Medical Branch

A biological mystery lies at the center of each of our cells, namely: how one meter of DNA can be wadded up into the space of a micron (or one millionth of a meter) within each nucleus of our body.

The nuclei of human cells are not even the most crowded biological place that we know of. Some bactiophagesviruses that infect and replicate within a bacteriumhave even more concentrated DNA.

"How does it get in there?" B. Montgomery (Monte) Pettitt, a biochemist and professor at the University of Texas Medical Branch, asks. "It's a charged polymer. How does it overcome the repulsion at its liquid crystalline density? How much order and disorder is allowed, and how does this play a role in nucleic acids?"

Using the Stampede and Lonestar5 supercomputers at The University of Texas at Austin's Texas Advanced Computing Center (TACC), Pettitt investigates how phages' DNA folds into hyper-confined spaces.

Writing in the June 2017 issue of the Journal of Computational Chemistry, he explained how DNA may overcome both electrostatic repulsion and its natural stiffness.

The key to doing so? Kinks.

The introduction of sharp twists or curves into configurations of DNA packaged within a spherical envelope significantly reduces the overall energies and pressures of the molecule, according to Pettitt.

He and his collaborators used a model that deforms and kinks the DNA every 24 base pairs, which is close to the average length that is predicted from the phage's DNA sequence. The introduction of such persistent defects not only reduces the total bending energy of confined DNA, but also reduces the electrostatic component of the energy and pressure.

"We show that a broad ensemble of polymer configurations is consistent with the structural data," he and collaborator Christopher Myers, also of University of Texas Medical Branch, wrote.

Insights like these cannot be gained strictly in the lab. They require supercomputers that serve as molecular microscopes, charting the movement of atoms and atomic bonds at length- and time-scales that are not feasible to study with physical experiments alone.

"In the field of molecular biology, there's a wonderful interplay between theory, experiment and simulation," Pettitt said. "We take parameters of experiments and see if they agree with the simulations and theories. This becomes the scientific method for how we now advance our hypotheses."

Problems like the ones Pettitt is interested in cannot be solved on a desktop computer or a typical campus cluster, but require hundreds of computer processors working in parallel to mimic the minute movements and physical forces of molecules in a cell.

Pettitt is able to access TACC's supercomputers in part because of a unique program known as the Journal of Computational Chemistry initiative, which makes TACC's computing resources, expertise and training available to researchers within the University of Texas Systems' 14 institutions.

"Computational research, like that of Dr. Pettitt, which seeks to bridge our understanding of physical, chemical, and ultimately biological phenomena, involves so many calculations that it's only really approachable on large supercomputers like TACC's Stampede or Lonestar5 systems," said Brian Beck, a life sciences researcher at TACC.

"Having TACC supercomputing resources available is critical to this style of research," Pettitt said.

FINDING THE ORDER IN DISORDERED PROTEINS

Another phenomenon that has long interested Pettitt is the behavior of Intrinsically Disordered Proteins (IDPs) and intrinsically disordered domains, where parts of a protein have a disordered shape.

Unlike crystals or the highly-packed DNA in viruses, which have distinct, rigid shapes, IDPs "fold up into a gooey mess," according to Pettitt. And yet they're critical for all forms of life.

It is believed that in eukaryotes (organisms whose cells have complex substructures like nuclei), roughly 30 percent of proteins have an intrinsically disordered domain. More than 60 percent of proteins involved in cell signaling (molecular processes that take signals from outside the cell or across cells that tell the cell what behaviors to turn on and off in response) have disordered domains. Similarly, 80 percent of cancer-related signaling proteins have IDP regions - making them important molecules to understand.

Among the IDPs Pettitt and his group are studying are nuclear transcription factors. These molecules control the expression of genes and have a signaling domain that is rich in the flexible amino acid, glycine.

The folding of the nuclear transcription factor signaling domain is not brought about by hydrogen bonding and hydrophobic effects, like most protein molecules, according to Pettitt. Rather, when the longer molecules find too many glycines in a space, they go beyond their solubility and start associating with each other in unusual ways.

"It's like adding too much sugar in your tea," Pettitt explains. "It won't get any sweeter. The sugar must fall out of solution and find a partner - precipitating into a lump."

Writing in Protein Science in 2015, he described molecular simulations performed on Stampede that helped to explain how and why IDPs collapse into globule-like structures.

The simulations calculated the forces from carbonyl (CO) dipole-dipole interactionsattractions between the positive end of one polar molecule and the negative end of another polar molecule. He determined that these interactions are more important in the collapse and aggregation of long strands of glycine than the formation of H-bonds.

"Given that the backbone is a feature of all proteins, CO interactions may also play a role in proteins of nontrivial sequence where structure is eventually determined by interior packing and the stabilizing effects of H-bonds and CO-CO interactions," he concluded.

The research was enabled by an allocation of compute time on Stampede through the Extreme Science and Engineering Discovery Environment (XSEDE) which is supported by the National Science Foundation.

Pettitt, a long-time champion of supercomputing, doesn't only use TACC resources himself. He encourages other scholars, including his colleagues at the Sealy Center for Structural Biology and Molecular Biophysics, to use supercomputers as well.

"Advanced computing is important for data analysis and data refinement from experiments, X-ray and electron microscopy, and informatics," he says. "All of these problems have big data processing issues that can be addressed using advanced computing."

When it comes to uncovering the mysteries of biology on the tiniest scales, nothing quite beats a giant supercomputer.

Explore further: Rosetta online server that includes everyone

More information: Christopher G. Myers et al, Phage-like packing structures with mean field sequence dependence, Journal of Computational Chemistry (2017). DOI: 10.1002/jcc.24727

Our bodies are made of biomolecules like proteins, nucleic acids, fats and sugars. These biomolecules are folded into specific 3D structurespredetermined by the DNA and RNA sequences that build themwhich allows them ...

Scientists at The Scripps Research Institute (TSRI) have brought physics and biology together to further understand how cells' crowded surfaces induce complex protein behavior.

Surgery and radiation remove, kill, or damage cancer cells in a certain area. But chemotherapywhich uses medicines or drugs to treat cancercan work throughout the whole body, killing cancer cells that have spread far ...

The last time you popped a pill for a headache or a stuffy nose, did you think about how the medication actually alleviates your pain or unblocks your stuffy nose? Curing a disease is a complex process and involves understanding ...

Even though it's almost impossible to see, computational biophysicist Rommie Amaro is using the Stampede supercomputer at the Texas Advanced Computing Center at The University of Texas at Austin to model the largest atomic ...

Using the largest computer in Japan - one of the most powerful in the world - research led by an MSU scientist has achieved breakthroughs in understanding how proteins are affected by realistic biological environments. The ...

In the battle of the batteries, lithium-ion technology is the reigning champion, powering that cellphone in your pocket as well as an increasing number of electric vehicles on the road.

(Phys.org)A team of researchers at Johannes Kepler University Linz has developed a new type of glue that can be used to bond hydrogels to other hard or soft objects. In their paper published on the open-access site Science ...

(Phys.org)The synthesis of carboxylic acid derivatives from unsaturated carbon compounds is important for making chemicals used in pharmaceuticals, cosmetics, polymers, and agrochemicals. In industry this reaction is done ...

During sepsis, cells are swamped with reactive oxygen species generated in an aberrant response of the immune system to a local infection. If this fatal inflammatory path could be interfered, new treatment schemes could be ...

Marijuana is now legal for recreational or medicinal use in at least 28 states and the District of Columbia. But driving under the influence of marijuana is illegal no matter which state you're in. To enforce the law, authorities ...

Researchers at The University of Manchester in collaboration with Central South University (CSU), China, have created a new kind of ceramic coating that could revolutionise hypersonic travel for air, space and defense purposes.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

The rest is here:
Researchers explore DNA folding, cellular packing with supercomputer simulations - Phys.Org

Posted in DNA | Comments Off on Researchers explore DNA folding, cellular packing with supercomputer simulations – Phys.Org

Ancient-genome studies grapple with Africa’s past – Nature.com

Posted: at 1:46 am

Chris Johns/NGC

Genome analysis of ancient people from Africa reveals a complicated migration history for the human species.

Ignored for too long by researchers, ancient humans who lived in Africa thousands of years ago are finally having their genomes studied. Two projects released results this week on the genomes of around 20 individuals, which together reveal that the history of our species on the continent was far more complex than previously thought.

Africas neglect until now by ancient-DNA researchers was largely down to the continents scorching climate. Because heat speeds the deterioration of DNA, scientists have focused on sequencing remains from cooler European sites and Siberian permafrost. The first success in Africa came in 2015 when researchers sequenced the genome of a 4,500-year-old man from Ethiopia who was preserved in a relatively chilly mountainous cave.

But advances in removing contamination and the discovery that a tinyinner ear bone is chock full ofancient DNA has convincedresearchers that the technology is finally ready to grapple withAfricas past.

Stephan Schiffels, a population geneticist at the Max Planck Institute for the Science of Human History, in Jena, Germany, says gaps in the knowledge of sub-Saharan African history are embarrassing especially in light of how much researchers know about ancient peoples in Eurasia. This makes it all the more important to use DNA to uncover Africa's hidden history of human migration, he says.

That is what a team led by Pontus Skoglund and David Reich, population geneticists at Harvard Medical School in Boston, Massachusetts, have now done. In a talk on 3 July at the Society for Molecular Biologys annual meeting in Austin, Texas, Skoglund said his team had examined the genomes of 15 ancient individuals and described detailed analysis of 11 of them who lived as long as 6,000 years ago in eastern and southern Africa.

They showed ancient humans moved around on the continent far more than was appreciated. The genome of a 3,000-year-old individual from Tanzania bore the ancestry of both ancient East African hunter-gatherers and early farmers from the Middle East. That supports past studies that documented a back to Africa migration several thousand years ago: these migrants were closely related to early farmers from the Levant region in the Middle East.

The Tanzanian fossil was found at an archaeological site linked to animal herding, or pastoralism, and some of its genetic signatures have also been found in present-day pastoralists in southern Africa, Skoglund said. This suggests that east Africans brought herding to southern Africa.

The unpublished study from Skoglunds team revealed additional movement. The genome of a 2,000-year-old individual from southern Africa was related to contemporary southern African hunter-gatherers known as the San, as well as to ancient hunter-gatherers the team sequenced from Malawi and Tanzania but not to the current inhabitants of eastern Africa.

The reason for this, Skoglund suggested, is a well-documented migration of Bantu groups from Western Africa, who brought agriculture and distinct language to eastern and southern Africa around 1,000-2,000 years ago. This Bantu expansion seems to have completely replaced local hunter-gatherers. An individual who lived on Tanzanias Zanzibar peninsula 750 year ago, after the migration, shared no ancestry with earlier hunter-gatherers from southern or east Africa.

A separate team, led by Mattias Jakobsson at Uppsala University in Sweden, found evidence for the same migrations in the genome of a boy who lived 2,000 years ago near Balito Bay in South Africa and 6 other ancient southern Africans. Their study1 was posted to the bioRxiv preprint server last month.

Proof of migrations such as the Bantu expansion have been found at archaeological sites, as well as in the DNA of contemporary Africans, says Schiffels. But it is still nice to have direct evidence of these movements, he notes.

Ancient African genomes also have the potential to illuminate much earlier events. Jakobssons team used the Ballito Bay boys genome to infer that Homo sapiens emerged at least 260,000 years ago far earlier than previous genetic studies have suggested. Skoglunds team, meanwhile, used their ancient genomes to help uncover a possible ghost population that diverged from the founding population of H. sapiens before any other African group and later contributed to the genetic make-up of some present-day West Africans.

IainMathieson, a population geneticist at the University of Pennsylvania in Philadelphia,hopes that ancient African DNA can explain our species migration out of Africa, some 50,000-100,000 years ago, by painting a genetic picture of the continents inhabitants around this time.

This might require DNA far older than several thousand years which could mandateanother major technical advance. Analysis of bones thought to be about 300,000 years old from Morocco, attributed to the earliest-known H. sapiens, has so far yielded no usable DNA. "It's early days," for ancient African genomics, says Mathieson, "it really is."

See more here:
Ancient-genome studies grapple with Africa's past - Nature.com

Posted in Genome | Comments Off on Ancient-genome studies grapple with Africa’s past – Nature.com

Wild wheat genome sequencing provides ‘time tunnel’ capable of … – Phys.Org

Posted: at 1:46 am

July 6, 2017 Wild Emmer wheat. Credit: Energin .R Technologies 2009 LTD.

A global team of researchers has published the first-ever Wild Emmer wheat genome sequence in Science magazine. Wild Emmer wheat is the original form of nearly all the domesticated wheat in the world, including durum (pasta) and bread wheat. Wild emmer is too low-yielding to be of use to farmers today, but it contains many attractive characteristics that are being used by plant breeders to improve wheat.

The study was led by Dr. Assaf Distelfeld of Tel Aviv University's School of Plant Sciences and Food Security and Institute for Cereal Crops Improvement, in collaboration with several dozen scientists from institutions around the world and an Israel-based company - NRGene, which developed the bioinformatics technology that accelerated the research.

"This research is a synergistic partnership among public and private entities," said Dr. Daniel Chamovitz, Dean of Tel Aviv University's George S. Wise Faculty of Life Sciences, who was also involved in the research. "Ultimately, this research will have a significant impact on global food safety and security."

"Our ability to generate the Wild Emmer wheat genome sequence so rapidly is a huge step forward in genomic research," said Dr. Curtis Pozniak from the University of Saskatchewan, a project team member and Chair of the Canadian Ministry of Agriculture Strategic Research Program. "Wheat accounts for almost 20% of the calories humans consume worldwide, so a strong focus on improving the yield and quality of wheat is essential for our future food supply."

The video will load shortly

"From a biological and historical viewpoint, we have created a 'time tunnel' we can use to examine wheat from before the origins of agriculture," said Dr. Distelfeld. "Our comparison to modern wheat has enabled us to identify the genes involved in domestication - the transition from wheat grown in the wild to modern day varieties. While the seeds of wild wheat readily fall off the plant and scatter, a change in two genes meant that in domesticated wheat, the seeds remained attached to the stalk; it is this trait that enabled humans to harvest wheat."

"This new resource allowed us to identify a number of other genes controlling main traits that were selected by early humans during wheat domestication and that served as foundation for developing modern wheat cultivars," said Dr. Eduard Akhunov of Kansas State University. "These genes provide an invaluable resource for empowering future breeding efforts. Wild Emmer is known as a source of novel variation that can help to improve the nutritional quality of grain as well as tolerance to diseases and water-limiting conditions."

"New genomic tools are already being implemented to identify novel genes for wheat production improvement under changing environment," explains Dr. Zvi Peleg of the Hebrew University of Jerusalem, Israel. "While many modern wheat cultivars are susceptible to water stress, Wild Emmer has undergone a long evolutionary history under the drought-prone Mediterranean climate. Thus, utilization of the wild genes in wheat breeding programs promotes producing more yield for less water." "The wheat genome is much more complex than most of the other crops and has agenome four times the size of a human genome." said Dr. Gil Ronen, NRGene's CEO. "Still, the computational technology we developed has allowed us to quickly assemble the very large and complex genome found in Wild Emmer's 14 chromosomes to a standard never achieved before in genomic studies."

For the first time, the sequences of the 14 chromosomes of Wild Emmer wheat are collapsed into a refined order, thanks to additional technology that utilizes DNA and protein links. "It was originally tested in humans and recently demonstrated in barley, both of which have smaller genomes than Wild Emmer wheat," says Dr. Nils Stein, the Head of Genomics of Genetic Resources at Leibniz Institute of Plant Genetics and Crop Plant Research in Germany. "These innovative technologies have changed the game in assembling the large cereal genomes."

"This sequencing approach used for Wild Emmer wheat is unprecedented and has paved the way to sequence durum wheat (the domesticated form of Wild Emmer). Now we can better understand how humanity transformed this wild plant into a modern, high-yielding and high-quality crop," said Dr. Luigi Cattivelli, Head of the CREA Research Centre for Genomics and Bioinformatics (Italy) and coordinator of the International Durum Wheat Genome Sequencing Consortium. "This Wild Emmer wheat sequencing and approach is an invaluable contribution to the entire wheat community to improve and better understand nutritional mechanisms," said Dr. Hikmet Budak, Montana Plant Science Endowed Chair at Montana State University.

"We now have the tools to study crops directly and to make and apply our discoveries more efficiently than ever before," concluded Dr. Distelfeld.

Explore further: A lesson from wheat evolution: From the wild to our spaghetti dish

More information: R. Avni el al., "Wild emmer genome architecture and diversity elucidate wheat evolution and domestication," Science (2017). science.sciencemag.org/cgi/doi 1126/science.aan0032

Journal reference: Science

Provided by: Tel Aviv University

While wheat has been much maligned recently for it's gluten content, and new suspicions casted about as to its nutritional value, scientists have been eager to trace the evolutionary history of wheat to better understand ...

Kansas State University wheat scientists have completed the first study of a chromosome in a tertiary gene pool and have called it a breakthrough in exploring wheat wild relatives for future crop improvement.

Increases in climate variability have placed new emphasis on the need for resilient wheat varieties. Alongside demands for increased resiliency, consumer interest in healthier, more functional foods is growing. Therefore, ...

The German Federal Ministry of Food and Agriculture announced today that it would award 1.5 million Euros to a project aimed at providing a reference sequence for two wheat chromosomes, part of the international effort to ...

A team of Spanish scientists, with the participation of the University of Granada, has carried out the first durum wheat genetic, phenotypic and geographic adaptation study to date. Durum wheat is mostly used for the production ...

The International Wheat Genome Sequencing Consortium (IWGSC) announced today the production of a whole genome assembly of bread wheat, the most widely grown cereal in the world, significantly accelerating global research ...

In butterflies, sex is determined by chromosome differences between males and females. But unlike in humans with the familiar X and Y, in butterflies, it is the females that determine the sex of offspring.

A University of Kentucky plant pathologist is part of an international team of researchers who have uncovered an important link to a disease which left unchecked could prove devastating to wheat. UK College of Agriculture, ...

A global team of researchers has published the first-ever Wild Emmer wheat genome sequence in Science magazine. Wild Emmer wheat is the original form of nearly all the domesticated wheat in the world, including durum (pasta) ...

After observing the mating habits of chacma baboons living in the wild over a four-year period, researchers have found that males of the species often use long-term sexual intimidation to control their mates. The findings ...

Bacteria of the Spiroplasma genus produce toxic, ribosome-inactivating proteins (RIPs) that appear to protect their symbiotic host flies against parasitic wasps, according to new research published in PLOS Pathogens.

Plants and brains are more alike than you might think: Salk scientists discovered that the mathematical rules governing how plants grow are similar to how brain cells sprout connections. The new work, published in Current ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

See original here:
Wild wheat genome sequencing provides 'time tunnel' capable of ... - Phys.Org

Posted in Genome | Comments Off on Wild wheat genome sequencing provides ‘time tunnel’ capable of … – Phys.Org

Every cancer patient could have DNA tested under five-year government plan to cut deaths – The Independent

Posted: at 1:46 am

A new era of genome-based personalised medicine could open up for cancer patients within five years under new plans unveiled by the Government's chief medical adviser.

The "genomics dream" outlined by Professor Dame Sally Davies would see millions of patients having all their DNA tested as genome sequencing becomes as routine as MRI or CT scans.

Ultimately, the future goal is for every cancer patient to have his or her whole genome sequenced, making the procedure as standard as blood tests and biopsies.

People with rare diseases are also expected to benefit from having greater access to the technology, ending the years long "diagnostic odyssey" of multiple tests and visits to different specialists.

Whole genome sequencing involves unscrambling the entire book of genetic instructions that make us what we are, encompassing 3.2 billion "letters" of code.

Research suggests that in 60 per centof cases, the genomes of cancer patients reveal "actionable" data - personal mutations that can shape future treatment.

Tens of thousands of NHS patients have already had their DNA mapped, but the new recommendations set out in Chief Medical Officer Dame Sally's "Generation Genome" report aim to multiply the numbers many times over.

Dame Sally said: "The age of precision medicine is now and the NHS must act fast to keep its place at the forefront of global science .

"This technology has the potential to change medicine forever - but we need all NHS staff, patients and the public to recognise and embrace its huge potential.

"Genomic medicine has huge implications for the understanding and treatment of rare diseases, cancer and infections."

Currently, genetic testing of NHS patients in England is conducted via 25 regional laboratories and a plethora of smaller ones operating along the lines of a "cottage industry", said Dame Sally.

Her chief recommendation is to centralise all the labs and establish a national network providing equal access to the tests across the country.

Within government, a new National Genomics Board would be set up, chaired by a minister, to oversee the expansion and development of genomic services taking into account new advances within the rapidly evolving technology.

Other proposals include offering every existing clinician training in genomics and ensuring their descendants are equipped to practise genomic medicine.

The report also recommends setting up a standing committee of experts to advise on the availability of genetic tests and indications for their use.

Lessons could be learned from the highly successful 100,000 Genomes Project, which has now sequenced more than 31,000 genomes from patients with cancer and rare diseases, said Dame Sally.

Her report calls for a simplified two-stage consent system that draws on the Genomes Project model and makes it easier for patients to get involved in research studies and clinical trials.

Speaking at a news briefing in London, Dame Sally said she hoped to see the new system fully operational within five years.

Part of what made greater access to whole genome sequencing feasible was the rapidly reducing cost of the tests, which has fallen from several thousand pounds to an average 680, she pointed out.

Results from analysis of cancer samples could now be delivered in as little as four weeks.

In the short term, she wanted to see "all appropriate patients" given the opportunity to have their genomes sequenced under the guidance of experts.

Wearable device could help fight brain cancer

Further down the line, she hoped the tests would become routine for every cancer patient.

Dame Sally said: "Yes, my dream is that, in the end, every patient gets their genome done if they've got cancer.

"It's not just their genome but its the cancer itself, and as the cancer changes over time and with treatment it will need redoing.

"But you go at it through what will give a worthwhile actionable result for the patients, and the experts will tell us."

Health Secretary Jeremy Hunt said he welcomed the report, pointing out that the UK had established itself as a world leader in genomics medicine.

He added: "Tens of thousands of patients across the country have already benefited from quicker diagnosis, precise treatment and care, and we will support the NHS to continue its relentless drive to push the boundaries of modern science to benefit even more people."

Press Association

Read the original post:
Every cancer patient could have DNA tested under five-year government plan to cut deaths - The Independent

Posted in Genome | Comments Off on Every cancer patient could have DNA tested under five-year government plan to cut deaths – The Independent

Scientists Home in on Eczema-Causing Germs – NBC News – NBCNews.com

Posted: at 1:46 am

Eczema patients had more Staphylococcus aureus bacteria (golden colonies) on their skin during active flare-ups. A.L. Byrd et al / Science Translational Medicine (2017)

And the team at the National Institutes of Health narrowed down the bad bacteria using genetic sequencing.

The hope is to figure out if the staph bacteria are causing the eczema or are a side-effect, and whether they worsen the symptoms. Eventually, it might be possible to use the knowledge to develop better treatments.

Atopic dermatitis (eczema) is a common inflammatory skin disorder in industrialized countries, affecting 10 to 30 percent of children, Julia Segre of the NIHs National Human Genome Research Institute and colleagues wrote.

Patients with atopic dermatitis suffer from chronic, relapsing, intensely itchy, and inflamed skin lesions and have an increased likelihood of developing asthma and/or hay fever.

Bacteria are a longtime suspect, and one treatment for eczema is a bleach bath to kill them off. But its not usually a long-term fix.

Related:

One team at NIH is working on

But its important to figure out just who the bad actors are, and thats what Segres team did.

They tested 18 children, 11 of whom had eczema. They scraped off the microbes living on their skin during flare-ups and outside of flare-ups, and sequenced the genomes of everything they found.

Staph bacteria were definitely the most variable and seemed most associated with eczema flare-ups, they found.

The more severe atopic dermatitis patients were markedly colonized with a single clade of S. aureus during disease flares, they wrote.

We found that less severe (eczema) patients were colonized with more methicillin-resistant strains, whereas the more severe (eczema) patients were primarily colonized with methicillin-sensitive strains.

Its not clear why. Methicillin-resistant Staphylococcus aureus (MRSA) has become very common across the U.S.

But understanding the differences between the various types of bacteria living on healthy skin and itchy skin could lead to ways to prevent allergies, the NIH team hopes.

Because eczema develops so early in life, scientists believe that the bacteria that take up residence on a babys skin can influence whether that child develops allergies. Getting rid of bad bacteria may help prevent the development of allergies, researchers believe.

Eczema is caused by a combination of genetic, immune and environmental factors.

There are many treatments out there now, from simple skin lotions to steroid creams and immune suppressant drugs like tacrolimus. But none of these works for everybody, and the immune suppressant drugs can raise the risk of cancers such as lymphoma.

The

Read more from the original source:
Scientists Home in on Eczema-Causing Germs - NBC News - NBCNews.com

Posted in Eczema | Comments Off on Scientists Home in on Eczema-Causing Germs – NBC News – NBCNews.com

Possible link found between eczema flare-ups and strain of bacteria – Medical Xpress

Posted: at 1:46 am

July 6, 2017 by Bob Yirka report Eczema patients had more Staphylococcus aureus bacteria (golden colonies) on their skin during active flare-ups. Credit: Carla Shaffer / AAAS

(Medical Xpress)A team of researchers with the National Institutes of Health in the U.S. has found what appears to be a link between eczema flare-ups and a certain strain of bacteria. In their paper published in Science Translational Medicine, the group outlines their study of the connection between the skin ailment and bacteria and what they found.

Eczema is a skin condition causing patches of skin to become itchy and discolored. Besides being an irritant, it also causes emotional problems because most patients are young people, including children. Some studies have also shown it can lead to an increased likelihood of developing allergies. Prior research has suggested it might be possible that the condition is caused by some type of bacteriasome researchers have even found possible candidates. But despite evidence of higher numbers of certain bacteria existing on the skin during flare-ups, no one has been able to figure out if they were a cause or a side effect. In this new effort, the researchers sought to prove they were a likely cause.

The suspected bacteria, a strain of Staphylococcus aureus, lives on most people's skin, but because it appears to reproduce dramatically during flare-ups, the researchers sought a link. They enlisted the assistance of 18 volunteers, all children, and 11 of whom had eczema. The researchers scraped their skin to collect bacterial samples. For those with eczema, samples were collected during flare-ups, between flare-ups and just after flare-ups. Those without eczema only had their skin scraped once to offer as a comparison.

The researchers report that S. aureus was much more prevalent during flare-ups in the volunteers. They also noted that patients who experienced less severe flare-ups had more methicillin-resistant strains of the bacteria than did those who experienced more severe symptoms.

To find out if the bacteria was the cause of the flare-ups or merely a side effect, the researchers collected samples of the bacteria during a flare up and applied it to the skin of test mice. They report that doing so caused skin inflammationmuch more so than when other strains of the same types of bacteria were applied.

The researchers acknowledge that their findings are not definitive proof that S. aureus causes eczema, but believe it indicates it is likely. More work needs to be done to determine why the bacteria suddenly multiply and to find out if there are other factors involved.

Explore further: Skin defences point to eczema therapies

More information: Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis, Science Translational Medicine (2017). DOI: 10.1126/scitranslmed.aal4651 , http://stm.sciencemag.org/content/9/397/eaal4651

Abstract The heterogeneous course, severity, and treatment responses among patients with atopic dermatitis (AD; eczema) highlight the complexity of this multifactorial disease. Prior studies have used traditional typing methods on cultivated isolates or sequenced a bacterial marker gene to study the skin microbial communities of AD patients. Shotgun metagenomic sequence analysis provides much greater resolution, elucidating multiple levels of microbial community assembly ranging from kingdom to species and strain-level diversification. We analyzed microbial temporal dynamics from a cohort of pediatric AD patients sampled throughout the disease course. Species-level investigation of AD flares showed greater Staphylococcus aureus predominance in patients with more severe disease and Staphylococcus epidermidis predominance in patients with less severe disease. At the strain level, metagenomic sequencing analyses demonstrated clonal S. aureus strains in more severe patients and heterogeneous S. epidermidis strain communities in all patients. To investigate strain-level biological effects of S. aureus, we topically colonized mice with human strains isolated from AD patients and controls. This cutaneous colonization model demonstrated S. aureus strainspecific differences in eliciting skin inflammation and immune signatures characteristic of AD patients. Specifically, S. aureus isolates from AD patients with more severe flares induced epidermal thickening and expansion of cutaneous T helper 2 (TH2) and TH17 cells. Integrating high-resolution sequencing, culturing, and animal models demonstrated how functional differences of staphylococcal strains may contribute to the complexity of AD disease.

2017 Medical Xpress

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Excerpt from:
Possible link found between eczema flare-ups and strain of bacteria - Medical Xpress

Posted in Eczema | Comments Off on Possible link found between eczema flare-ups and strain of bacteria – Medical Xpress

Paolo Bediones admits suffering from psoriasis – ABS-CBN News

Posted: at 1:46 am

Paolo Bediones. Facebook.com/paolo.bediones

MANILA - Host Paolo Bediones surprised his social media followers when he admitted that he is suffering from psoriasis.

In a Facebook post on July 5, Bediones said he has been keeping his condition a secret "for more than half my life."

He turned 43 last March.

"I HAVE PSORIASIS. Don't worry, it's a non-communicable skin disorder. It is NOT CONTAGIOUS. It's a painful, chronic disease characterized by incessant itching and scratching. Occasional bleeding and scabbing. Reddening of the skin and flaking. It's not pretty for sure, but I have been hiding it well," he wrote in the post, which has been shared more than 1,000 times as of writing.

Bediones went on to shed light on the plight of his fellow psoriasis patients in the country.

"More than 2 million of my KABALAT in the country suffer the daily plight of flare ups that are mild to severe, that happen during bouts of stress and heat, and sometimes it's caused by the food we eat. Some have even perished from the ordeal.

"Every day we have to mentally prepare ourselves before we go out into the world. Each one of us insecure, knowing someone will notice the discolored patch of skin or the white flakes. Knowing someone would like to ask about it, but feel uncomfortable doing so," he said.

The TV anchor then asked the public to show their support for psoriasis patients and encourage them to seek treatment.

"If you, a family member, or a friend share these symptoms, look up Psor Phil and please see a specialist and learn about the various forms of treatment that exists. If you know anyone with psoriasis, hug them. If you see me on the street, hug me," he ended.

Other celebrities who have opened up about suffering from psoriasis include reality TV star Kim Kardashian and singer Britney Spears.

See the rest here:
Paolo Bediones admits suffering from psoriasis - ABS-CBN News

Posted in Psoriasis | Comments Off on Paolo Bediones admits suffering from psoriasis – ABS-CBN News

"Scandal" Star Opens Up About Her Experience with Psoriasis – KDRV

Posted: at 1:46 am


KDRV
"Scandal" Star Opens Up About Her Experience with Psoriasis
KDRV
She says right around the time she started the big role, she was diagnosed with psoriasis. The disease causes red, scaly patches on the skin that itch and burn. Not only is it painful, some say it can be embarrassing. Katie Lowes says she dealt with ...

Continued here:
"Scandal" Star Opens Up About Her Experience with Psoriasis - KDRV

Posted in Psoriasis | Comments Off on "Scandal" Star Opens Up About Her Experience with Psoriasis – KDRV

CMO Samsung BioLogics Inks Deal to Manufacture Plaque Psoriasis Inhibitor – Pharmaceutical Processing

Posted: at 1:46 am

Sun Pharma and Samsung BioLogics announce strategic manufacturing tie-up for tildrakizumab.

Sun Pharmaand Samsung BioLogics announced a strategic long-term manufacturing agreement for tildrakizumab. The agreement was entered into by Sun Pharma's wholly owned subsidiary and Samsung BioLogics. According to the agreement, Sun Pharma has appointed Samsung BioLogics to manufacture tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis.

Filings for the novel investigational biologic was accepted for review by the U.S. Food and Drug Administration (FDA) in May and the European Medicines Agency (EMA) in March. The agreement was signed at Samsung BioLogics' headquarters in Incheon,South Korea. The approximate value of the contract will be $55.5 million. Other financial details of the agreement were confidential.

"Samsung BioLogics is a globally renowned CMO. Through this partnership we will leverage Samsung's manufacturing knowledge and world class quality systems to provide high quality products for the tildrakizumab pipeline,"Kirti Ganorkar, global headportfolio management and business development atSun Pharma, said.

Tildrakizumab is an investigational humanized, anti-IL-23p19 monoclonal antibody designed to selectively block the cytokine IL-23. With this precise targeting, tildrakizumab has the potential to help control the pathogenic cells responsible for the inflammatory process of psoriasis with limited impact on the rest of the immune system.

Phase-3 tildrakizumab data provide further evidence for the role of the IL-23 pathway in helping to control the inflammatory process of psoriasis. The regulatory filings associated with tildrakizumab have been accepted for review by the FDA and EMA.

A Sun Pharmaceutical Industries Ltd. wholly owned subsidiary received worldwide rights to tildrakizumab from Merck, known as MSD outsidethe United StatesandCanada, in 2014. Funded by a Sun Pharma subsidiary, Merck is responsible for the completion of Phase-3 trials in patients with mild-to-moderate plaque psoriasis and, as appropriate, submission of a Biologics License Application to the United States Food and Drug Administration (FDA). Merck is also responsible for manufacturing finished goods to support Sun Pharma's initial product launch.

Post-approval in the U.S., Sun Pharma will be responsible for all other regulatory activities, including subsequent submissions, pharmacovigilance, post approval studies, manufacturing and commercialization of the approved product. Sun Pharma will also be responsible for all regulatory, pharmacovigilance, post approval studies, manufacturing and commercialization of approved products for all non-U.S. markets. Merck is eligible to receive milestone payments and royalties on sales of tildrakizumab.

(Source: PR Newswire)

Originally posted here:
CMO Samsung BioLogics Inks Deal to Manufacture Plaque Psoriasis Inhibitor - Pharmaceutical Processing

Posted in Psoriasis | Comments Off on CMO Samsung BioLogics Inks Deal to Manufacture Plaque Psoriasis Inhibitor – Pharmaceutical Processing